Overview

A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-01-30

Target enrollment:

Participant gender:

Summary

This pooled analysis will assess Cognitive, Mental Health, Functioning, and Quality of Life Assessments data from the Phase 3 registration studies INSPiRE-ICU 1 (NCT05312385) and INSPiRE-ICU 2 (NCT05327296) to explore potential differences in Long-Term Outcomes at 3 and 6 months after treatment between critically ill mechanically ventilated patients sedated with inhaled isoflurane compared to sedated with intravenous propofol. The analyses were pre-planned and agreed prior to completion of enrollment of either study.

Phase:

PHASE3

Details

Lead Sponsor:

Sedana Medical

Collaborator:

Critical Illness, Brain Dysfunction, and Survivorship Center